Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for Children Release Date: | Quality Improvement | Vaccines | Japan | |
Efforts to Improve Quality of Migraine Medical Care Release Date: Partner: The Japanese Headache Society | Quality Improvement | Internal Medicine | Japan | |
Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older Adults Release Date: | Quality Improvement | Vaccines | Japan | |
Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care Release Date: Partner: Conquer Cancer, the ASCO Foundation | Quality Improvement | Oncology | USA | |
The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries Release Date: Partner: AMFROM | Quality Improvement | Oncology | Benin, Congo, The Democratic Republic, Mali, Senegal, Togo | |
Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer Release Date: | Education | Oncology | USA | |
Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC) | Education | Oncology | USA | |
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
COVID-19 Disease Burden on the Pediatric Population Release Date: | Education | Vaccines | USA | |
Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing Research Release Date: | Education | Vaccines | USA | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates Release Date: | Education | Vaccines | USA | |
Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China Release Date: | Research | Inflammation & Immunology | China | |
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder Release Date: | Education | Internal Medicine | Japan | |
Interventional Research Studies with Elranatamab Release Date: | Research | Oncology | All | |
Research in Ulcerative Colitis (UC) 2024 Release Date: | Research | Inflammation & Immunology | Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey | |
Advances in the Management of Ulcerative Colitis (UC) Release Date: | Education | Inflammation & Immunology | All | |
Research in Ulcerative Colitis (UC) 2024 Release Date: | Research | Inflammation & Immunology | Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom | |
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Release Date: | Research | Oncology | USA | |
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma Release Date: | Education | Oncology | Japan | |
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia Release Date: | Research | Hospital | Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom | |
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States) Release Date: | Education | Rare Disease | All | |
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT) | Education | Oncology | USA |